Skip to main content
OpenTrials
Completed

NCT Number: NCT01003847

Differential Metabolic Effects of Fenofibrate and Fatty Acid

The investigators hypothesize that fenofibrate and fatty acid may have different metabolic effects in hypertriglyceridemic patients

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Gil Medical Center

Incheon, 405-760, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • hypertriglyceridemia

Exclusion criteria

  • Overt liver disease Chronic renal failure Hypothyroidism Myopathy Uncontrolled diabetes Severe hypertension

Treatment and study plan

fenofibrate, fatty acid, placebo

Drug

fenofibrate 160 mg, fatty acids 2 gm, placeob 8 weeks of treatment

Primary outcomes

  1. flow-mediated dilation

    Time frame: 8 weeks of treatment

Secondary outcomes

  1. insulin resistance

    Time frame: 8 weeks of treatment

Sponsors and collaborators

Lead sponsor

Gachon University Gil Medical Center

Other

Registry information

Important dates

Study start
2009
Primary completion
2010
Study completion
2010
First posted
Oct 29, 2009
Registry last updated
May 10, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.